Similar medications and substitutes for BEVACIZUMAB-BVZR
In short: Zirabev (BEVACIZUMAB-BVZR) belongs to the Vascular Endothelial Growth Factor Inhibitor class. The medications listed below either share that mechanism of action or have been clinically validated as substitutes when Zirabev is unsuitable due to side effects, cost, availability, or contraindications.
No alternatives are listed for Zirabev in our database yet. Browse the full medicine index or consult your pharmacist for substitution advice.